WILLIAMS AND JENSEN, PLLC

Lobbying for RAYNER · Manufacturer of ophthalmic medical products.

Filing 1st Quarter - Termination

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $30,000.00 income · posted Apr 20, 2026

Lobbying activity 1

Medicare/Medicaid

Medicare coverage issue for non-opioid product. Reauthorization of NOPAIN Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem